SENSEX NIFTY
Panacea Biotec Yearly Results, Panacea Biotec Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Yearly Results - Panacea Biotec
Panacea Biotec
BSE: 531349|NSE: PANACEABIO|ISIN: INE922B01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 30, 13:05
166.00
0.35 (0.21%)
VOLUME 3,828
LIVE
NSE
Jul 30, 13:10
166.60
-1.1 (-0.66%)
VOLUME 13,981
Download Annual Report PDF Format 2013 | 2012 | 2011 | 2010

Yearly Results of Panacea Biotec

------------------- in Rs. Cr. -------------------
Mar '14 Mar '13 Mar '12 Mar '11 Mar '10
Net Sales/Income from operations 467.14 530.42 688.38 1,152.39 909.77
Other Operating Income 35.89 65.50 12.20 -- --
Total Income From Operations 503.03 595.92 700.58 1,152.39 909.77
EXPENDITURE
Consumption of Raw Materials 196.58 236.37 302.39 445.76 501.49
Purchase of Traded Goods 22.39 23.26 24.52 -- --
Increase/Decrease in Stocks -10.89 0.29 20.56 58.87 -51.48
Power & Fuel -- -- -- -- --
Employees Cost 142.73 137.23 150.45 129.39 99.02
Depreciation 68.80 83.54 75.39 73.11 66.45
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- 107.93 86.39
R & D Expenses -- -- 91.87 59.46 --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 246.71 263.33 157.86 87.70 56.92
P/L Before Other Inc. , Int., Excpt. Items & Tax -163.29 -148.10 -122.46 190.17 150.98
Other Income 11.64 5.43 7.46 13.12 5.37
P/L Before Int., Excpt. Items & Tax -151.65 -142.67 -115.00 203.29 156.35
Interest 145.79 113.79 95.39 47.80 38.27
P/L Before Exceptional Items & Tax -297.44 -256.46 -210.39 155.49 118.08
Exceptional Items 297.02 5.83 -10.41 -- --
P/L Before Tax -0.42 -250.63 -220.80 155.49 118.08
Tax -- -20.50 -55.15 20.44 38.06
P/L After Tax from Ordinary Activities -0.42 -230.13 -165.65 135.05 80.02
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -42.14 -- --
Net Profit/(Loss) For the Period -0.42 -230.13 -207.79 135.05 80.02
Equity Share Capital 6.13 6.13 6.13 6.13 6.68
Reserves Excluding Revaluation Reserves 172.96 182.82 422.65 630.68 689.82
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS -0.07 -37.57 -33.92 21.35 --
Diluted EPS -0.07 -37.57 -33.92 21.35 --
EPS After Extra Ordinary
Basic EPS -0.07 -37.57 -33.92 21.35 --
Diluted EPS -0.07 -37.57 -33.92 21.35 --
Public Share Holding
No Of Shares (Crores) 1.54 1.54 1.54 1.54 2.09
Share Holding (%) 25.19 25.19 25.19 25.08 31.27
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) 4.58 4.58 4.58 4.58 --
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 99.92 --
- Per. of shares (as a % of the total Share Cap. of the company) 74.81 74.81 74.81 74.63 --
Notes Notes To The Accounts Notes To The Accounts
Source : Dion Global Solutions Limited
Quick Links for panaceabiotec
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.